Your browser doesn't support javascript.
loading
Biology-inspired microphysiological systems to advance patient benefit and animal welfare in drug development
Marx, Uwe; Akabane, Takafumi; Andersson, Tommy B; Baker, Elizabeth; Beilmann, Mario; Beken, Sonja; Brendler-Schwaab, Susanne; Cirit, Murat; David, Rhiannon; Dehne, Eva-Maria; Durieux, Isabell; Ewart, Lorna; Fitzpatrick, Suzanne C; Frey, Olivier; Fuchs, Florian; Griffith, Linda G; Hamilton, Geraldine A; Hartung, Thomas; Hoeng, Julia; Hogberg, Helena; Hughes, David J; Ingber, Donald E; Iskandar, Anita; Kanamori, Toshiyuki; Kojima, Hajime; Kuehnl, Jochen; Leist, Marcel; Li, Bo; Loskill, Peter; Mendrick, Donna L; Neumann, Thomas; Pallocca, Giorgia; Rusyn, Ivan; Smirnova, Lena; Steger-Hartmann, Thomas; Tagle, Danilo A; Tonevitsky, Alexander; Tsyb, Sergej; Trapecar, Martin; Van de Water, Bob; Van den Eijnden-van Raaij, Janny; Vulto, Paul; Watanabe, Kengo; Wolf, Armin; Zhou, Xiaobing; Roth, Adrian.
Afiliação
  • Marx U; TissUse GmbH, Berlin, Germany.
  • Akabane T; Technische Universitaet Berlin, Germany.
  • Andersson TB; Stem Cell Evaluation Technology Research Association, Tokyo, Japan.
  • Baker E; DMPK, Research and Early Development Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • Beilmann M; Physicians Committee for Responsible Medicine, Washington DC, USA.
  • Beken S; Boehringer Ingelheim Pharma GmbH & Co. KG, Non-clinical Drug Safety, Biberach, Germany.
  • Brendler-Schwaab S; Federal Agency for Medicines and Health Products, Brussels, Belgium.
  • Cirit M; BfArM, Bonn, Germany.
  • David R; Javelin Biotech, Inc, Woburn, MA, USA.
  • Dehne EM; Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Cambridge, UK
  • Durieux I; TissUse GmbH, Berlin, Germany.
  • Ewart L; TissUse GmbH, Berlin, Germany.
  • Fitzpatrick SC; Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Cambridge, UK
  • Frey O; US Food and Drug Administration, Center for Food Safety and Applied Nutrition, College Park, MD, USA.
  • Fuchs F; InSphero, Schlieren, Switzerland.
  • Griffith LG; Novartis Institutes for BioMedical Research Chemical Biology & Therapeutics, Basel, Switzerland.
  • Hamilton GA; Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Hartung T; Emulate Inc., Boston, USA.
  • Hoeng J; Center for Alternatives to Animal Testing, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.
  • Hogberg H; Center for Alternatives to Animal Testing-Europe, University of Konstanz, Konstanz, Germany.
  • Hughes DJ; AxoSim, Inc., New Orleans, LA, USA
  • Ingber DE; Philip Morris International R&D, Neuchâtel, Switzerland.
  • Iskandar A; Center for Alternatives to Animal Testing, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.
  • Kanamori T; CN Bio Innovations Ltd., Welwyn Garden City, UK.
  • Kojima H; Wyss Institute for Biology Inspired Engineering, Harvard University, Boston, USA.
  • Kuehnl J; Philip Morris International R&D, Neuchâtel, Switzerland.
  • Leist M; National Institute of Advanced Industrial Science and Technology (AIST), Tokyo, Japan.
  • Li B; Japanese Center for Validation of Animal Methods, Tokyo, Japan.
  • Loskill P; Beiersdorf, Hamburg, Germany.
  • Mendrick DL; Center for Alternatives to Animal Testing-Europe, University of Konstanz, Konstanz, Germany.
  • Neumann T; National Center for Safety Evaluation of Drugs, National Institutes for Food and Drug Control, Beijing, P.R. China.
  • Pallocca G; Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB, Stuttgart, Germany.
  • Rusyn I; Faculty of Medicine, Eberhard Karls University Tübingen, Tübingen, Germany.
  • Smirnova L; National Center for Toxicological Research, FDA, Silver Spring, MD, USA.
  • Steger-Hartmann T; Nortis Inc., Seattle WA, USA.
  • Tagle DA; Center for Alternatives to Animal Testing-Europe, University of Konstanz, Konstanz, Germany.
  • Tonevitsky A; Texas A&M University, College Station, TX, USA.
  • Tsyb S; Center for Alternatives to Animal Testing, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.
  • Trapecar M; Bayer, Investigational Toxicology, Berlin, Germany.
  • Van de Water B; National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD, USA.
  • Van den Eijnden-van Raaij J; M.M. Shemyakin & Yu.A. Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Russia.
  • Vulto P; National Research University Higher School of Economics, Russia.
  • Watanabe K; Russian Ministry of Production and Trade, Moscow, Russia.
  • Wolf A; Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Zhou X; Universiteit Leiden, Leiden, The Netherlands.
  • Roth A; Institute for Human Organ and Disease Model Technologies, Eindhoven, The Netherlands.
ALTEX ; 37(3): 365-394, 2020.
Article em En | MEDLINE | ID: mdl-32113184
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Bem-Estar do Animal / Avaliação Pré-Clínica de Medicamentos / Dispositivos Lab-On-A-Chip / Desenvolvimento de Medicamentos / Alternativas aos Testes com Animais Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Bem-Estar do Animal / Avaliação Pré-Clínica de Medicamentos / Dispositivos Lab-On-A-Chip / Desenvolvimento de Medicamentos / Alternativas aos Testes com Animais Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article